Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US Read more
Nadda urges industry, academia collaboration to build better healthcare at Healthcare Summit at IIMA Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more
Zydus signs agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary Read more
Indian pharma companies focus on innovative research in foreign countries through dedicated entities Read more